PYC Therapeutics Ltd
ASX:PYC
Income Statement
Earnings Waterfall
PYC Therapeutics Ltd
Revenue
|
21.5m
AUD
|
Operating Expenses
|
-42.8m
AUD
|
Operating Income
|
-21.2m
AUD
|
Other Expenses
|
-395.6k
AUD
|
Net Income
|
-21.6m
AUD
|
Income Statement
PYC Therapeutics Ltd
Jun-2006 | Dec-2006 | Jun-2007 | Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
1
+121%
|
1
+27%
|
1
-14%
|
1
+44%
|
1
+14%
|
1
-4%
|
1
-38%
|
1
-25%
|
2
+275%
|
2
+5%
|
2
-18%
|
2
-1%
|
1
-63%
|
1
-1%
|
1
+86%
|
1
-47%
|
1
+7%
|
1
+8%
|
0
-94%
|
0
N/A
|
3
N/A
|
3
+0%
|
0
-99%
|
0
+21%
|
0
-82%
|
0
-97%
|
0
N/A
|
3
N/A
|
3
+5%
|
3
+17%
|
9
+191%
|
16
+73%
|
13
-16%
|
16
+18%
|
22
+36%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
+135%
|
1
+43%
|
1
-16%
|
1
+52%
|
1
-32%
|
1
-14%
|
(0)
N/A
|
(0)
-83%
|
2
N/A
|
2
+16%
|
1
-30%
|
1
-1%
|
0
-88%
|
0
N/A
|
1
+350%
|
0
-83%
|
0
+25%
|
0
+55%
|
(1)
N/A
|
(1)
-32%
|
2
N/A
|
2
-12%
|
(1)
N/A
|
(1)
-1%
|
(1)
-8%
|
(2)
-33%
|
(3)
-48%
|
0
N/A
|
(3)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||
Operating Expenses |
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(5)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(8)
|
(8)
|
(6)
|
(5)
|
(5)
|
(10)
|
(10)
|
(22)
|
(34)
|
(30)
|
(38)
|
(39)
|
(43)
|
|
Selling, General & Administrative |
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(4)
|
(3)
|
(1)
|
(2)
|
(4)
|
(3)
|
(5)
|
(7)
|
(9)
|
(5)
|
(5)
|
(3)
|
(3)
|
|
Research & Development |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(4)
|
(5)
|
(5)
|
(3)
|
(1)
|
(6)
|
(4)
|
(14)
|
(25)
|
(24)
|
(33)
|
(35)
|
(39)
|
|
Depreciation & Amortization |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(4)
N/A
|
(4)
+13%
|
(4)
-7%
|
(5)
-14%
|
(4)
+1%
|
(5)
-13%
|
(4)
+11%
|
(4)
+11%
|
(5)
-14%
|
(3)
+32%
|
(4)
-16%
|
(4)
-14%
|
(4)
+5%
|
(6)
-41%
|
(5)
+4%
|
(5)
+15%
|
(5)
-15%
|
(5)
+2%
|
(5)
+1%
|
(6)
-15%
|
(6)
-7%
|
(4)
+39%
|
(4)
-11%
|
(10)
-124%
|
(10)
-2%
|
(8)
+19%
|
(7)
+10%
|
(8)
-10%
|
(7)
+9%
|
(10)
-44%
|
(19)
-82%
|
(25)
-35%
|
(14)
+43%
|
(25)
-73%
|
(23)
+6%
|
(21)
+9%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(4)
N/A
|
(4)
+13%
|
(4)
-10%
|
(5)
-13%
|
(4)
+3%
|
(5)
-13%
|
(4)
+11%
|
(4)
+11%
|
(5)
-14%
|
(3)
+32%
|
(4)
-16%
|
(4)
-14%
|
(4)
+5%
|
(6)
-41%
|
(5)
+4%
|
(4)
+16%
|
(5)
-13%
|
(5)
+2%
|
(5)
+0%
|
(6)
-14%
|
(6)
-7%
|
(4)
+39%
|
(4)
-13%
|
(9)
-125%
|
(10)
-2%
|
(8)
+19%
|
(7)
+10%
|
(8)
-10%
|
(7)
+8%
|
(10)
-45%
|
(19)
-82%
|
(17)
+7%
|
(14)
+18%
|
(25)
-73%
|
(23)
+6%
|
(22)
+7%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
2
|
4
|
2
|
3
|
3
|
2
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(4)
|
(4)
|
(5)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(2)
|
(5)
|
(7)
|
(5)
|
(4)
|
(5)
|
(7)
|
(13)
|
(19)
|
(17)
|
(14)
|
(25)
|
(23)
|
(22)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
|
Net Income (Common) |
(4)
N/A
|
(4)
+6%
|
(4)
-4%
|
(4)
-14%
|
(4)
-1%
|
(5)
-13%
|
(4)
+11%
|
(4)
+11%
|
(5)
-14%
|
(3)
+32%
|
(4)
-16%
|
(4)
-14%
|
(4)
+5%
|
(4)
+7%
|
(3)
+5%
|
(3)
+22%
|
(3)
-22%
|
(3)
+8%
|
(3)
0%
|
(4)
-21%
|
(4)
-10%
|
(4)
+7%
|
(2)
+47%
|
(5)
-157%
|
(7)
-48%
|
(5)
+35%
|
(4)
+16%
|
(5)
-28%
|
(7)
-30%
|
(12)
-77%
|
(18)
-47%
|
(17)
+5%
|
(14)
+18%
|
(24)
-71%
|
(23)
+4%
|
(22)
+5%
|
|
EPS (Diluted) |
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|